Currying the heart: Curcumin and cardioprotection

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 14, Issue 1, 2009, Pages 22-27

  Srivastava, Geetika ^a   Mehta, Jawahar L ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cardiac function; Curcumin; Ischemia; Oxidative stress; Signaling

Indexed keywords

ACID PHOSPHATASE; CATHEPSIN D; COLLAGEN; CURCUMIN; DOXORUBICIN; GELATINASE B; GLUCOSAMINIDASE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P300; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOTOXICITY; CELL ACTIVATION; CELL ADHESION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART INJURY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARDIOVASCULAR AGENTS; CURCUMIN; DOXORUBICIN; ENDOTHELIUM, VASCULAR; HEART DISEASES; HUMANS; ISOPROTERENOL; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 61449133232     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248408329608     Document Type: Review

References (29)

1. Sudano I., Spieker LE, Hermann F., et al. Protection of endothelial function: targets for nutritional and pharmacological interventions. J Cardiovasc Pharmacol. 2006; 47 (suppl 2). S136 - S150; discussion S172 - S176.
2. Spieker LE, Luscher TF Protection of endothelial function. Handbook Exp Pharmacol. 2005; 619-644.
3. Werns SW, Lucchesi BR Inflammation and myocardial infarction. Br Med Bull. 1987; 43: 460-471.
4. Molavi B., Mehta JL Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol. 2004; 19: 488-493.
5. Griendling KK, FitzGerald GA Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 2003; 108: 1912-1916.
6. Taniyama Y., Griendling KK Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003; 42: 1075-1081.
7. Deng MC, Roeder N., Plenz G., et al. [Proinflammatory cytokines and cardiac pump function]. Z Kardiol. 1997; 86: 788-802.
8. Stull LB, Matteo RG, Sweet WE, Damron DS, Schomisch Moravec C. Changes in calcium cycling precede cardiac dysfunction during autoimmune myocarditis in mice. J Mol Cell Cardiol. 2001; 33: 449-460.
9. Kim YS, Ahn Y., Hong MH, et al. Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells. J Cardiovasc Pharmacol. 2007; 50: 41-49.
10. Farhangkhoee H., Khan ZA, Chen S., Chakrabarti S. Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab (Lond). 2006; 3: 27.
11. Sumbilla C., Lewis D., Hammerschmidt T., Inesi G. The slippage of the Ca2+ pump and its control by anions and curcumin in skeletal and cardiac sarcoplasmic reticulum. J Biol Chem. 2002; 277: 13900-13906.
12. Abuarqoub H., Green CJ, Foresti R., Motterlini R. Curcumin reduces cold storage-induced damage in human cardiac myoblasts. Exp Mol Med. 2007; 39: 139-148.
13. Nirmala C., Puvanakrishnan R. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol Cell Biochem. 1996; 159: 85-93.
14. Nirmala C., Puvanakrishnan R. Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats. Biochem Pharmacol. 1996; 51: 47-51.
15. Nirmala C., Anand S., Puvanakrishnan R. Curcumin treatment modulates collagen metabolism in isoproterenol induced myocardial necrosis in rats. Mol Cell Biochem. 1999; 197: 31-37.
16. Yeh CH, Chen TP, Wu YC, Lin YM, Jing Lin P. Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. J Surg Res. 2005; 125: 109-116.
17. Yeh CH, Lin YM, Wu YC, Lin PJ Inhibition of NF-kappa B activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression. J Cardiovasc Pharmacol. 2005; 45: 301-309.
18. Cheng H., Liu W., Ai X. Protective effect of curcumin on myocardial ischemia reperfusion injury in rats. Zhong Yao Cai. 2005; 28: 920-922.
19. Venkatesan N. Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol. 1998; 124: 425-427.
20. Yao QH, Wang DQ, Cui CC, et al. Curcumin ameliorates left ventricular function in rabbits with pressure overload: inhibition of the remodeling of the left ventricular collagen network associated with suppression of myocardial tumor necrosis factor-alpha and matrix metalloproteinase-2 expression. Biol Pharm Bull. 2004; 27: 198-202.
21. Tharaux PL, Chatziantoniou C., Fakhouri F., Dussaule JC Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension. 2000 ; 36: 330-336.
22. Morimoto T., Sunagawa Y., Kawamura T., et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest. 2008; 118: 868-878.
23. Li HL, Liu C., de Couto G., et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest. 2008; 118: 879-893.
24. Sano M., Minamino T., Toko H., et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007; 446: 444-448.
25. Rafiee P., Shi Y., Pritchard KA Jr, et al. Cellular redistribution of inducible Hsp70 protein in the human and rabbit heart in response to the stress of chronic hypoxia: role of protein kinases. J Biol Chem. 2003; 278: 43636-43644.
26. Rafiee P., Shi Y., Kong X., et al. Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection. Circulation. 2002; 106: 239-245.
27. Sato M., Cordis GA, Maulik N., Das DK SAPKs regulation of ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2000; 279: H901 - H907.
28. Kolar F., Ostadal B. Molecular mechanisms of cardiac protection by adaptation to chronic hypoxia. Physiol Res. 2004; 53 (suppl 1). S3 - S13.
29. Nandagopal K., Dawson TM, Dawson VL Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther. 2001; 297: 474-478.